Ambroxol
From Wikipedia, the free encyclopedia
 |
|
|
Ambroxol
|
|
| Systematic (IUPAC) name | |
| trans-4-(2-Amino-3,5-dibrombenzylamino)-cyclohexanol | |
| Identifiers | |
| CAS number | |
| ATC code | R05 |
| PubChem | |
| Chemical data | |
| Formula | C13H18Br2N2O |
| Mol. mass | 378.10 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Ambroxol is a mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan or Mucoangin.
It is also a metabolite of the closely related bromhexine.
